Evidence map›Paper›PMID 39433894›Full record

ArticleScientific reports2024

A novel multifunctional chiral metasurface with asymmetric transmission.

Muhammad Noman, Hattan Abutarboush, Farooq A Tahir, Adnan Zahid, Muhammad Imran, Qammer H Abbasi

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Muhammad NomanJames Watt School of Engineering, University of Glasgow, Glasgow, G12 8QQ, UK.
Hattan AbutarboushCollege of Engineering, Taibah University, Madinah, Saudi Arabia.
Farooq A TahirJames Watt School of Engineering, University of Glasgow, Glasgow, G12 8QQ, UK.
Adnan ZahidSchool of Engineering and Physical Science, Heriot Watt University, Edinburgh, EH14 4AS, UK.
Muhammad ImranJames Watt School of Engineering, University of Glasgow, Glasgow, G12 8QQ, UK.
Qammer H AbbasiJames Watt School of Engineering, University of Glasgow, Glasgow, G12 8QQ, UK. qammer.abbasi@glasgow.ac.uk.

Funding

Engineering and Physical Sciences Research Council EP/X040518/1, EP/T021020/1, and EP/Y037421/1
6 · The paper itself

Abstract

The multiband, multifunctional chiral metasurface with asymmetric transmission exhibits significant potential for diverse applications in modern communication systems, ranging from enhanced signal modulation and polarization control to advanced beam steering and compact antenna design. This research presents a versatile and advanced chiral metasurface operating at multiple bands with diverse functionalities, including asymmetric transmission. The proposed metasurface effectively transforms an incoming Linearly Polarized (LP) wave into a Circularly Polarized (CP) wave. Additionally, it functions as a 90° polarization rotator for the incident LP wave. The design starts with an element of a 2 × 2 supercell comprising a Square Split Ring Resonator (SSRR) and an I-shaped resonator. The right diagonal elements of a supercell undergo scaling down, giving rise to a rotational asymmetry. Chirality is introduced into the design, and cross polarization conversion is enhanced by rotating all four elements by 90° relative to each other. On the back side of the substrate, each element undergoes a 90° rotation compared to its counterpart on the front side, realizing the asymmetric transmission feature. The incorporation of multiband and multifunctional features within a single supercell equips the subject chiral metasurface to be utilized in various engineering applications.

Identifiers

PMID39433894
PMCPMC11493989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.